Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-09

Clinical Trial Update: Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design [NA]

View source ↗

Summary

A terminated clinical trial by Viatris (Pfizer Upjohn/Mylan merger) investigated measuring pain reduction in spinal cord injury patients using a new study desig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Spinal Cord Injuries | NA | Status: TERMINATED | Results posted: 2009-11-09